Thursday
SESSION V: A NEW CRITICAL LOOK AT CAROTID STENTING (CAS) AND EMBOLIC BRAIN PROTECTION DEVICES (7-MINUTE TALKS)
SESSION V SCHEDULE
11:12 AM - 11:19 AM Carotid Echomorphology Correlates With Embolic Risk During CAS: Should Protection Devices Be Used Selectively?
  Presenters(s): Peter H. Lin, M.D.  
  View Abstract
11:20 AM - 11:27 AM Debate: In CAS, Embolic Injury Is Not The Only Risk To The Brain
  Presenters(s): Sumaira Macdonald, MBChB (Comm), MRCP, FRCR, PhD  
  View Abstract
11:28 AM - 11:35 AM Debate: In CAS, Embolic Injury To The Brain Is The Main Problem
  Presenters(s): Klaus D. Mathias, M.D.  
11:36 AM - 11:43 AM Hemodynamic Changes During CAS Cause Half The Complications: How Can They Be Prevented?
  Presenters(s): Marc R.H. van Sambeek, M.D., Ph.D.  
  View Abstract
11:44 AM - 11:51 AM Debate: Why The 2-Year SAPPHIRE Trial Results Are So Good For CAS Enthusiasts
  Presenters(s): Kenneth Ouriel, M.D., F.A.C.S., F.A.C.C.  
  View Abstract
11:52 AM - 11:59 AM Debate: Limitations To The Value Of The SAPPHIRE Trial
  Presenters(s): Peter R.F. Bell, M.D., F.R.C.S., D.S.C., K.B.E.  
  View Abstract
12:00 PM - 12:07 PM Lessons Learned To Date From CREST: Why We Need The Randomized Phase Of CREST
  Presenters(s): Robert W. Hobson II, M.D.  
12:08 PM - 1:08 PM Lunch Break
END OF SESSION V